USPTO trademark

NUZOLVENCE

RegisteredUSPTOWord and designClass 5Class 44

"NUZOLVENCE" is a word and design mark owned by Entasis Therapeutics (Ireland) Limited, filed at the USPTO on October 1, 2025. It is registered and covers classes 5 and 44.

Get this data via the API

Data current as of August 11, 2026Official USPTO record

As filed with the USPTO

Status: Registered; Since August 11, 2026
Filed: October 1, 2025
Registered: August 11, 2026
Priority date: September 24, 2025; Claimed from European Union
Application no.: 99423851
Registration no.: 8388237
Office: USPTO; United States Patent and Trademark Office
Mark type: Word and design; 2 classes

Ownership

Who owns NUZOLVENCE

The owner and representative on file with the office.

Owner

Entasis Therapeutics (Ireland) Limited

Dublin 4, Ireland

Representative

Keith Toms, Esq.

McCarter & English, LLP

Goods and services

What the mark covers

The products and services NUZOLVENCE is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Antibiotics; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of gonorrhea; Pharmaceutical preparations for the treatment of sexually transmitted diseases
44Class 44 · Medical, Beauty, and Agricultural
Providing medical information in the field of infectious diseases; Providing medical information in the field of gonorrhea; Providing medical information in the field of sexually transmitted diseases

History

What has happened so far

Steps recorded by the USPTO, newest first.

August 11, 2026Notice of registration confirmation emailed
August 11, 2026Registered-principal register
June 23, 2026Official gazette publication confirmation e-mailed
June 23, 2026Published for opposition
June 17, 2026Notification of notice of publication e-mailed
May 22, 2026Approved for pub - principal register
May 22, 2026Notification of examiners amendment e-mailed
May 22, 2026Examiner's amendment entered
May 22, 2026Examiners amendment e-mailed
May 22, 2026Examiners amendment -written

10 earlier steps on the official record.

FAQ

About NUZOLVENCE

Who owns the trademark "NUZOLVENCE"?

The USPTO trademark "NUZOLVENCE" (application 99423851) is owned by Entasis Therapeutics (Ireland) Limited.

What is the status of "NUZOLVENCE"?

Its status at the USPTO is: registered.

When was "NUZOLVENCE" registered?

It was registered on August 11, 2026.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NUZOLVENCE and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2b3b-ac6d-74a2-a7f0-d74c7a968d26
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2b3b-ac6d-74a2-a7f0-d74c7a968d26",
  "object": "trademark",
  "mark_text": "NUZOLVENCE",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "99423851",
  "filing_date": "2025-10-01",
  "nice_classes": [
    5,
    44
  ],
  "owners": [
    {
      "name": "Entasis Therapeutics (Ireland) Limited",
      "entity_id": null
    }
  ]
}